Active, not recruiting means the trial is running but enrollment is closed
BPC-157 / TB-500 is a research peptide blend combining two well-studied synthetic peptides: Body Protection Compound-157 (BPC-157) and Thymosin Beta-4 fragment TB-500. BPC-157 is a stable gastric pentadecapeptide originally derived from human gastric juice, while TB-500 is a synthetic peptide modeled after the naturally occurring thymosin beta-4. Together, this blend is formulated for laboratory research focused on tissue repair, angiogenesis, and cellular regeneration pathways
For many people, the symptom fades as the body adapts
Could expert-guided care be the support youve been searching for
Just as results increase with a higher dose, so do potential side effects
If you normally inject at 8 PM Eastern and fly to California, inject at 8 PM Pacific